SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001346302-20-000045
Filing Date
2020-07-01
Accepted
2020-07-01 17:25:06
Documents
22
Period of Report
2020-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xers-20200701.htm   iXBRL 8-K 65562
2 EX-4.1 exh41baseindenture.htm EX-4.1 572963
3 EX-4.2 exh42firstsupplemental.htm EX-4.2 1001529
9 image11.jpg GRAPHIC 9188
10 image21.jpg GRAPHIC 12927
11 image31.jpg GRAPHIC 12610
12 image41.jpg GRAPHIC 10681
13 image51.jpg GRAPHIC 9093
14 image61.jpg GRAPHIC 15689
  Complete submission text file 0001346302-20-000045.txt   2101231

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20200701.xsd EX-101.SCH 2420
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20200701_cal.xml EX-101.CAL 708
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20200701_def.xml EX-101.DEF 15623
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20200701_lab.xml EX-101.LAB 30040
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20200701_pre.xml EX-101.PRE 16292
15 EXTRACTED XBRL INSTANCE DOCUMENT xers-20200701_htm.xml XML 11488
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 201006144
SIC: 2834 Pharmaceutical Preparations